What is Channel Medsystems?
Founded in 2009, Channel Medsystems operates at the intersection of medical device innovation and women's health. The company is dedicated to the research, development, and commercialization of treatments designed to meet the specific requirements of female patients and the rigorous standards of their healthcare providers. By prioritizing clinical efficacy and technological advancement, Channel Medsystems has established a robust market position, leveraging its Berkeley headquarters to tap into a dense ecosystem of life sciences talent and research capabilities. The firm's portfolio reflects a deep understanding of the complexities inherent in minimally invasive procedures, aiming to improve patient outcomes while streamlining the delivery of care.
How much funding has Channel Medsystems raised?
Channel Medsystems has raised a total of $54.8M across 5 funding rounds:
Series A
$1M
Series B
$9.8M
Debt
$6M
Private Equity
$23.9M
Series C
$14.1M
Series A (2012): $1M, investors not publicly disclosed
Series B (2013): $9.8M, investors not publicly disclosed
Debt (2014): $6M, investors not publicly disclosed
Private Equity (2015): $23.9M, investors not publicly disclosed
Series C (2017): $14.1M backed by Aperture Venture Partners, LLC, Scientific Health Development, InCube Ventures, Boston Scientific, Third Point Ventures, and Longwood Fund
Key Investors in Channel Medsystems
Aperture Venture Partners, LLC
A healthcare-focused investment firm that collaborates with entrepreneurs to develop innovative companies in the medical device, pharmaceutical, and healthcare IT sectors.
Scientific Health Development
A Dallas-based venture capital firm specializing in early-stage medtech companies that address unmet clinical needs with capital-efficient, adoptable technologies.
InCube Ventures
A multi-disciplinary life sciences R&D lab led by prolific inventor Mir Imran, focused on developing breakthrough medical innovations and new standards of care.
What's next for Channel Medsystems?
With the support of its recent capital injection, Channel Medsystems is well-positioned to accelerate its commercialization efforts and expand its footprint in the global medtech market. The company's strategic roadmap likely involves scaling its manufacturing capabilities and deepening its clinical evidence base to support broader adoption of its proprietary technologies. As the firm transitions into a more mature phase of its lifecycle, the focus will shift toward navigating regulatory milestones and strengthening its competitive moat against established medical device incumbents. Continued collaboration with its diverse investor base will be critical in sustaining this momentum and achieving long-term value creation in the specialized women's health segment.
See full Channel Medsystems company page
